Anil K. Agarwal
Anil K. Agarwal received his Ph.D. degree while working at the Central Drug Research Institute, Lucknow, India (awarded by the University of Kanpur), where he was later appointed as a Scientist. He subsequently spent four years at The Population Council, The Rockefeller University, and the Department of Pediatrics, Weill Medical College, Cornell University. Dr. Agarwal later moved to the Southwestern Medical Center, University of Texas, Dallas, where he is an Associate Professor at the Department of Internal Medicine. He is a Member of The Endocrine Society and is on the Editorial Board of the Journal of Clinical Endocrinology and Metabolism and Molecular Nutrition and Food Research. Dr. Agarwal has made major contributions to the molecular biology and genetics of steroid metabolism and lipodystrophies. He and his coworkers have shown that mutations in 11-beta hydroxysteroid dehydrogenase type 2 (11HSD2) cause the syndrome of apparent mineralocorticoid excess and that mutations in ZMPSTE24 cause mandibuloacral dysplasia. Dr. Agarwal’s current research focus is to understand the molecular basis of more common diseases like diabetes, insulin resistance, and loss of fat (adipose tissue), which is a common feature of the lipodystrophies.
Biography Updated on 15 April 2008